SEC Form 4 · accession 0001127602-15-014531

Elevance Health, Inc. · ELV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Gloria M McCarthy

Officer — EVP & Chief Administrative Off

Period of report

Apr 13, 2015

Accepted (ET)

Apr 15, 2015 · 4:10 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001156039

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Apr 13, 2015	M	13,936	$61.88	A	72,031	D
Common Stock	Apr 13, 2015	M	11,491	$65.98	A	83,522	D
Common Stock	Apr 13, 2015	M	18,506	$66.23	A	102,028	D
Common Stock^F2	Apr 13, 2015	S	18,405	$154.65	D	83,623	D
Common Stock^F3	Apr 13, 2015	S	25,528	$155.28	D	58,095	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Buy)^F4	$61.88	Apr 13, 2015	M	13,936	D	—	Mar 1, 2020	Common Stock	13,936	6,968	D
Employee Stock Option (Right to Buy)^F5	$65.98	Apr 13, 2015	M	11,491	D	—	Mar 1, 2018	Common Stock	11,491	0	D
Employee Stock Option (Right to Buy)^F6	$66.23	Apr 13, 2015	M	18,506	D	—	Mar 1, 2019	Common Stock	18,506	0	D

Explanation of responses

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2015.
F2This transaction was executed in multiple trades at prices ranging from $154.10 to $155.09. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3This transaction was executed in multiple trades at prices ranging from $155.10 to $155.64. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4The option, representing a right to purchase a total of 20,904 shares, became exercisable in six equal semi-annual installments of 3,484 shares each beginning on September 1, 2013, which was the six-month anniversary of the date on which the option was granted.
F5The option, representing a right to purchase a total of 11,491 shares, became exercisable in five equal semi-annual installments of 1,915 shares each and one semi-annual installment of 1,916 shares beginning on September 1, 2011, which was the six-month anniversary of the date on which the option was granted.
F6The option, representing a right to purchase a total of 18,506 shares, became exercisable in four equal semi-annual installments of 3,084 shares each and two equal semi-annual installments of 3,085 shares each beginning on September 1, 2012, which was the six-month anniversary of the date on which the option was granted.